A minority of studies used the standard three-point MACE endpoint, and many tweaked their endpoints along the way.

Updated guidance on preventing atherosclerotic cardiovascular disease in people with dyslipidemia includes changes reflecting ...

Think of your loved ones — your family, friends, people you work with, or even the people in your community. Can you name ...

Heart health is important all year round and can be protected by choosing an organic diet, as supported by scientific studies ...

Lerodalcibep is an adnectin-based, small protein-binding, third generation proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor.

Evercore ISI analyst Liisa Bayko raised the price target for CRISPR Therapeutics from $60.00 to $99.00. Bayko's optimism is driven by upcoming catalysts that could mark a new chapter for the company.

What’s the full story? Seaport lays out a bullish case, starting with the massive total addressable market for groceries, ...

American Association of Clinical Endocrinology (AACE) guidelines offer evidence-based recommendations for the pharmacologic management of dyslipidemia in adults, emphasizing the ...

Using hormone replacement therapy (HRT) to reduce cardiovascular risk during menopause remains a topic of debate. The ...

Seha Virtual Hospital (SVH) isn't just another telehealth platform—it's the world's largest virtual hospital - with a ...

To control cholesterol levels, people are encouraged to follow a healthy diet, observe weight management, and get regular exercise ...